Problem based review: The morbidly obese patient

Acute Medicine

Volumn 11, Issue 2, 2012, Pages 107-112

  Maggs, Fenella G ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; D DIMER; ENOXAPARIN; FUROSEMIDE; GLICLAZIDE; IBUPROFEN; METFORMIN; OMEPRAZOLE; PARACETAMOL; RAMIPRIL; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTICOAGULANT THERAPY; BARIATRIC SURGERY; BODY SIZE; CASE REPORT; CHOLECYSTECTOMY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART RIGHT VENTRICLE FAILURE; HOSPITAL BED; HUMAN; INTERTRIGO; KNEE OSTEOARTHRITIS; LEG SWELLING; LIVER FUNCTION TEST; LUNG EMBOLISM; MEDICAL HISTORY; METABOLIC SYNDROME X; MORBID OBESITY; OBESITY HYPOVENTILATION SYNDROME; PALPATION; PULMONARY HYPERTENSION; REHABILITATION CARE; RESPIRATORY FAILURE; REVIEW; SKIN SCAR; SLEEP APNEA SYNDROME; TACHYPNEA; THORAX PAIN;

BARIATRIC SURGERY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MIDDLE AGED; OBESITY, MORBID;

EID: 84865316614     PISSN: 17474884     EISSN: 17474892     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Information Centre for health and social care. The health survey for England - 2008 trend tables. London: Health and Social Care Information Centre, 2009.
2. Lobstein T and Jackson Leach R. International comparisons of obesity trends, determinants and responses. Evidence review. Foresight Tackling Obesities, 2007: Future Choices http://www.foresight.gov.uk.
3. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. NICE guideline CG43 2006.
4. Yusuf S, Hawken S, Ôunpuu S, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. The Lancet 2005; 366: 1640-1649.
5. Booth CMA, Moore CE, Eddleston J, et al. Patient safety incidents associated with obesity: a review of reports to the National Patient Safety Agency and recommendations for hospital practice. Postgrad Med J 2011; 87: 694-699.
6. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-96.
7. Wolf HK, Tuomilehto J, Kuulasmaa K et al. Blood pressure levels in the 41 populations of the WHO MONICA project. J Hum Hypertens 1997; 11: 733-42.
8. Kastarinen MJ, Nissinen AM, Vartiainen EA, et al. Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. J Hypertens 2000; 18: 255-62.
9. Kenchaiah S, Gaziano JM and Vasan RS. Impact of obesity on the risk of heart failure and survival after the onset of heart failure. Med Clin North Am 2004; 88: 1273-94.
10. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 2004; 364: 937-952.
11. Ni Mhurchu C, Rodgers A, Pan WH, et al. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol 2004; 33: 751-8.
12. Yosipovitch G, DeVore A and Dawn A. Obesity and the skin: Skin physiology and skin manifestations of obesity. J Am Acad Dermatol 2007; 6: 901-916
13. Wannamethee SG and Shaper AG. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 1999; 22: 1266-72.
14. Green BB, Weiss NS and Daling JR. Risk of ovulatory infertility in relation to body weight. Fertil Steril 1998; 50: 721-26.
15. Anand G and Katz PO. Gastroesophageal reflux disease and obesity. Rev Gastroenterol Disord 2008; 8: 233-9.
16. Bigal ME and Lipton RB. Obesity and chronic daily headache. Curr Pain Headache Rep 2008 12: 56-61.
17. Beydoun MA, Beydoun HA and Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-analysis. Obes Rev 2008; 9: 204-18.
18. Munger KL, Chitnis T and Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology 2009; 73: 1543-50
19. Ejerblad E, Fored CM, Lindblad P et al. Obesity and risk for chronic renal failure. J. Am. Soc. Nephrol. 2006; 17: 1695-702.
20. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003 348: 1625-38.
21. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230-35.
22. Larsen F and Rössner S. Serum creatine kinase in obese subjects before and during weight reduction. Clin Chim Acta 1983; 133: 285-288.
23. Mills PJ, Shapiro D, Goldstein IB et al. Metabolic predictors of inflammation, adhesion, and coagulability in healthy younger-aged adults. Obesity 2008; 16: 2702-2706.
24. Lee DH, Ha MH and Christiani DC. Body weight, alcohol consumption and liver enzymes activity - a 4-year follow-up study. Int J Epidemiol 2001; 30: 766-70.
25. Sikaris KA. The clinical biochemistry of obesity - more than skin deep. Heart Lung Circ 2007; 16: S45-S50.
26. Uppot RN, Sahani DV, Hahn PF, et al. Effect of obesity on image quality: Fifteen-year longitudinal study for evaluation of dictated radiology reports. Radiology 2006; 240: 435-439.
27. Sanderink G, Liboux A, Jariwala N, et al. The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers. Clin Pharmacol Ther 2002; 72: 308-318.
28. Spinler S, Inverso S, Cohen M, et al. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J 2003; 146: 33-41.
29. Cheymol G. Clinical pharmacokinetics of drugs in obesity. An update. Clin Pharmacokinet 1993 25:103-114.
30. Cheymol G. Effects of obesity on pharmacokinetics. Implications for drug therapy. Clin Pharmacokinet 2000; 39: 215-231.
31. Hanley MJ, Abernethy DR and Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010 49: 71-87.
32. Chaves LC, Faintuch J, Kahwage S, et al. A cluster of polyneuropathy and Wernicke-Korsakoff syndrome in a bariatric unit. Obes Surg 2002; 12: 328-334.
33. De Prisco C and Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci 2005; 329: 57-61.
34. Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric bypass surgery. N Engl J Med 2005; 353: 249-254.
35. Shiffman ML, Sugerman HJ, Kellum JM, et al. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991; 86: 1000-1005.
36. Nasr SH, D'Agati VD, Said SM, et al. Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an under recognized cause of irreversible renal failure. Clin J Am Soc Nephrol 2008; 3: 1676-1683.
37. de Oliveira LD, Diniz MT, de Fátima H S et al. Rhabdomyolysis after bariatric surgery by Roux-en-Y gastric bypass: a prospective study. Obes Surg 2009; 19: 1102-1107.